Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre C Kalil

Showing results (211-220 of 277) with videos related to

Pageof 28
Sort By:
Journal of Comparative Effectiveness Research|February 29, 2024
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational studyEssy Mozaffari, Aastha Chandak, Robert L Gottlieb, et al.
Journal of Racial and Ethnic Health Disparities|February 27, 2024
Racial and Ethnic Disparities in COVID-19 Treatments in the United StatesEssy Mozaffari, Aastha Chandak, Alpesh N Amin, et al.
Transplantation|May 15, 2010
Adenovirus infections in pediatric small bowel transplant recipientsDiana F Florescu, Monirul K Islam, David F Mercer, et al.
Plos One|October 15, 2015
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic HistopathologyR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2023
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical PracticeEssy Mozaffari, Aastha Chandak, Robert L Gottlieb, et al.
Open Forum Infectious Diseases|June 19, 2024
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental OxygenEssy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, et al.
Shock (Augusta, Ga.)|February 11, 2004
Effects of drotrecogin alfa (activated) in human endotoxemiaAndre C Kalil, Susette M Coyle, John Y Um, et al.
Open Forum Infectious Diseases|October 23, 2023
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 VariantsEssy Mozaffari, Aastha Chandak, Robert L Gottlieb, et al.
Critical Care Medicine|April 2, 2008
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of AmericaNaomi P O'Grady, Philip S Barie, John G Bartlett, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 13, 2021
Prediction models in CMILeonard Leibovici, Jesús Rodríguez-Baño, Roy F Chemaly, et al.
Pageof 28

Showing results (211-220 of 277) with videos related to

Sort By:
Pageof 28
Journal of Comparative Effectiveness Research|February 29, 2024
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational studyEssy Mozaffari, Aastha Chandak, Robert L Gottlieb, et al.
Journal of Racial and Ethnic Health Disparities|February 27, 2024
Racial and Ethnic Disparities in COVID-19 Treatments in the United StatesEssy Mozaffari, Aastha Chandak, Alpesh N Amin, et al.
Transplantation|May 15, 2010
Adenovirus infections in pediatric small bowel transplant recipientsDiana F Florescu, Monirul K Islam, David F Mercer, et al.
Plos One|October 15, 2015
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic HistopathologyR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2023
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical PracticeEssy Mozaffari, Aastha Chandak, Robert L Gottlieb, et al.
Open Forum Infectious Diseases|June 19, 2024
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental OxygenEssy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, et al.
Shock (Augusta, Ga.)|February 11, 2004
Effects of drotrecogin alfa (activated) in human endotoxemiaAndre C Kalil, Susette M Coyle, John Y Um, et al.
Open Forum Infectious Diseases|October 23, 2023
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 VariantsEssy Mozaffari, Aastha Chandak, Robert L Gottlieb, et al.
Critical Care Medicine|April 2, 2008
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of AmericaNaomi P O'Grady, Philip S Barie, John G Bartlett, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 13, 2021
Prediction models in CMILeonard Leibovici, Jesús Rodríguez-Baño, Roy F Chemaly, et al.
Pageof 28